Knowledge, attitudes and practices of business travelers regarding influenza and the use of antiviral medicationArchived
This descriptive study evaluated knowledge, attitudes and practices of Swiss business travelers with regards to influenza and the use of anti-viral medication.
Global Review of recent Antiviral Resistance dataArchived
Each year in February WHO convenes a meeting with advisers from the WHO Influenza Collaborating Centres and Essential Reference laboratories in order to achieve consensus and advise WHO on the optimal formulation of seasonal influenza vaccines for the next influenza season.
The use of Interferon-γ release assays for Tuberculosis Screening in International TravelersArchived
IGRAs are increasingly being considered for the diagnosis of LTBI, as a replacement to the TST, including travel medicine. As with the TST, many uncertainties remain with regard to the efficacy of the IGRAs. It is therefore essential to secure an accurate understanding of these assays‘ known efficacy, so that they be optimally used and only in context with proven effect.
Obesity and 2009 pandemic influenza A(H1N1) – its role and implications as an important risk factor for the development of severe influenza diseaseArchived
2 papers are reviewed: A Novel Risk Factor for a Novel Virus: Obesity and 2009 Pandemic Influenza A (H1N1) and Morbid Obesity as a Risk Factor for Hospitalization and Death Due to 2009 Pandemic Influenza A(H1N1) Disease.
ECDC helps Romania meet its challenges in controlling TBArchived
During a recent country visit to Romania, ECDC emphasised the key issues for TB control. Following the invitation of the Romania Ministry of Health, ECDC disease experts, led by ECDC Director Marc Sprenger, visited the Marius Nasta Institute, which historically has been in the front line for TB control in the country.
ECDC and WHO Europe release “MESSAGE” - a tool to assess progress towards measles and rubella eliminationArchived
ECDC and WHO Europe jointly release “MESSAGE - MEaSles and rubella Self Assessment GEnerating tool” for public health experts, to facilitate assessment of the progress made towards measles and rubella elimination.
ECDC Director to the Informal Health Council on EHEC/STEC outbreak: Strengthen EU cooperation against epidemics essentialArchived
In his speech to the Informal Health Council on 5th July, ECDC Director Marc Sprenger outlined the lessons learnt from the EHEC/STEC outbreak in EU, as well as the need to strengthen EU cooperation against epidemics.
Using Geographic Information Systems and Decision Support Systems for the Prediction, Prevention, and Control of Vector-Borne DiseasesArchived
Emerging and resurging vector-borne diseases cause significant morbidity and mortality, especially in the developing world. We focus on how advances in mapping, Geographic Information System, and Decision Support System technologies, and progress in spatial and space time modeling, can be harnessed to prevent and control these diseases.
Poor pregnancy outcomes associated with maternal infection with the A(H1N1) 2009 virus during the pandemic – findings from a European cohort studyArchived
This large national cohort study followed-up pregnant women admitted to hospital and found to have laboratory-confirmed influenza A(H1N1) 2009 infection during the autumn-winter wave of the 2009 pandemic. The main objective was determining any adverse pregnancy outcomes attributable to the infection.